A Randomized, Multicenter, Open-Label, Phase 2 Study of TRK-950 in Combination with Ramucirumab and Paclitaxel As Second-Line Therapy in Patients with CAPRIN-1 Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma.
Journal of Clinical Oncology（2024）
关键词
298-145-222-184-1022-9124,298-7687-2370-7650-2700,3282-3301-4686-7432-7462,283-9769-3573-426,78,3620,3620,38092-22447,38116-38094-8
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要